▶ 調査レポート

世界の巣状分節性糸球体硬化症（FSGS）の治療市場：市場規模・現状・予測
• 英文タイトル：Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の巣状分節性糸球体硬化症（FSGS）の治療市場：市場規模・現状・予測 / Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7216資料のイメージです。• レポートコード：QYR9N7216
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、巣状分節性糸球体硬化症（FSGS）の治療のグローバル市場について調査・分析したレポートで、種類別（薬物療法、透析、腎臓移植）、用途別（一次FSGS、二次FSGS）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・巣状分節性糸球体硬化症（FSGS）の治療の世界市場規模
・主要企業別市場シェア
・巣状分節性糸球体硬化症（FSGS）の治療の世界市場規模：種類別（薬物療法、透析、腎臓移植）
・巣状分節性糸球体硬化症（FSGS）の治療の世界市場規模：用途別（一次FSGS、二次FSGS）
・巣状分節性糸球体硬化症（FSGS）の治療のアメリカ市場規模（種類別、用途別）
・巣状分節性糸球体硬化症（FSGS）の治療のヨーロッパ市場規模（種類別、用途別）
・巣状分節性糸球体硬化症（FSGS）の治療の中国市場規模（種類別、用途別）
・巣状分節性糸球体硬化症（FSGS）の治療の日本市場規模（種類別、用途別）
・巣状分節性糸球体硬化症（FSGS）の治療の東南アジア市場規模（種類別、用途別）
・巣状分節性糸球体硬化症（FSGS）の治療のインド市場規模（種類別、用途別）
・巣状分節性糸球体硬化症（FSGS）の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・巣状分節性糸球体硬化症（FSGS）の治療の世界市場予測（2019年-2025年）
・巣状分節性糸球体硬化症（FSGS）の治療の地域別市場予測（2019年-2025年）
...

Focal segmental glomerulosclerosis (FSGS) is a type of rare kidney disease that affects the kidney’s filtering system (glomeruli) resulting in proteinuria and serious scarring. Focal segmental glomerulosclerosis (FSGS) is usually fatal since it causes kidney failure within four to nine years followed by dialysis and then death. FSGS advances much more swiftly than diabetic nephropathy. Massive proteinuria, nephrotic syndrome, edema, hyperlipidemia, and hypoalbuminemia are some of the common symptoms of the disease. Risk factors include obesity, infection, sickle cell disease and reflux nephropathy.The market for FSGS treatment is primarily driven by the increasing disease burden, rising focus towards rare diseases, and increased R&D activity. Geographical analysis shows that North America is expected to maintain its dominance in this market, particularly due to well-structured healthcare facilities, early adoption of therapies and diagnosis options, and better reimbursement policies, as compared to other regions.
In 2018, the global Focal Segmental Glomerulosclerosis (FSGS) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Focal Segmental Glomerulosclerosis (FSGS) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Focal Segmental Glomerulosclerosis (FSGS) Treatment development in United States, Europe and China.

The key players covered in this study
B. Braun Melsungen
Medtronic
Pfizer
Complexa
Dimerix
Retrophin
Beckman Coulter Inc. (Danaher)
Boston Scientific Corporation
ChemoCentryx
Variant Pharmaceuticals

Market segment by Type, the product can be split into
Drug Therapy
Dialysis
Kidney Transplant

Market segment by Application, split into
Primary FSGS
Secondary FSGS

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Focal Segmental Glomerulosclerosis (FSGS) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Focal Segmental Glomerulosclerosis (FSGS) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Focal Segmental Glomerulosclerosis (FSGS) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Therapy
1.4.3 Dialysis
1.4.4 Kidney Transplant
1.5 Market by Application
1.5.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Application (2014-2025)
1.5.2 Primary FSGS
1.5.3 Secondary FSGS
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size
2.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Growth Trends by Regions
2.2.1 Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Regions (2014-2025)
2.2.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Manufacturers
3.1.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Key Players Head office and Area Served
3.3 Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Product/Solution/Service
3.4 Date of Enter into Focal Segmental Glomerulosclerosis (FSGS) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type (2014-2019)
4.2 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size (2014-2019)
5.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Key Players in United States
5.3 United States Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type
5.4 United States Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application

6 Europe
6.1 Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size (2014-2019)
6.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Key Players in Europe
6.3 Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type
6.4 Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application

7 China
7.1 China Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size (2014-2019)
7.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Key Players in China
7.3 China Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type
7.4 China Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application

8 Japan
8.1 Japan Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size (2014-2019)
8.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Key Players in Japan
8.3 Japan Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type
8.4 Japan Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size (2014-2019)
9.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type
9.4 Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application

10 India
10.1 India Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size (2014-2019)
10.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Key Players in India
10.3 India Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type
10.4 India Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size (2014-2019)
11.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Key Players in Central & South America
11.3 Central & South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type
11.4 Central & South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application

12 International Players Profiles
12.1 B. Braun Melsungen
12.1.1 B. Braun Melsungen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Focal Segmental Glomerulosclerosis (FSGS) Treatment Introduction
12.1.4 B. Braun Melsungen Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
12.1.5 B. Braun Melsungen Recent Development
12.2 Medtronic
12.2.1 Medtronic Company Details
12.2.2 Company Description and Business Overview
12.2.3 Focal Segmental Glomerulosclerosis (FSGS) Treatment Introduction
12.2.4 Medtronic Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
12.2.5 Medtronic Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Focal Segmental Glomerulosclerosis (FSGS) Treatment Introduction
12.3.4 Pfizer Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Complexa
12.4.1 Complexa Company Details
12.4.2 Company Description and Business Overview
12.4.3 Focal Segmental Glomerulosclerosis (FSGS) Treatment Introduction
12.4.4 Complexa Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
12.4.5 Complexa Recent Development
12.5 Dimerix
12.5.1 Dimerix Company Details
12.5.2 Company Description and Business Overview
12.5.3 Focal Segmental Glomerulosclerosis (FSGS) Treatment Introduction
12.5.4 Dimerix Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
12.5.5 Dimerix Recent Development
12.6 Retrophin
12.6.1 Retrophin Company Details
12.6.2 Company Description and Business Overview
12.6.3 Focal Segmental Glomerulosclerosis (FSGS) Treatment Introduction
12.6.4 Retrophin Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
12.6.5 Retrophin Recent Development
12.7 Beckman Coulter Inc. (Danaher)
12.7.1 Beckman Coulter Inc. (Danaher) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Focal Segmental Glomerulosclerosis (FSGS) Treatment Introduction
12.7.4 Beckman Coulter Inc. (Danaher) Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
12.7.5 Beckman Coulter Inc. (Danaher) Recent Development
12.8 Boston Scientific Corporation
12.8.1 Boston Scientific Corporation Company Details
12.8.2 Company Description and Business Overview
12.8.3 Focal Segmental Glomerulosclerosis (FSGS) Treatment Introduction
12.8.4 Boston Scientific Corporation Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
12.8.5 Boston Scientific Corporation Recent Development
12.9 ChemoCentryx
12.9.1 ChemoCentryx Company Details
12.9.2 Company Description and Business Overview
12.9.3 Focal Segmental Glomerulosclerosis (FSGS) Treatment Introduction
12.9.4 ChemoCentryx Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
12.9.5 ChemoCentryx Recent Development
12.10 Variant Pharmaceuticals
12.10.1 Variant Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Focal Segmental Glomerulosclerosis (FSGS) Treatment Introduction
12.10.4 Variant Pharmaceuticals Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
12.10.5 Variant Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Focal Segmental Glomerulosclerosis (FSGS) Treatment Key Market Segments
Table Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Covered
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Market Share by Type 2014-2025
Figure Drug Therapy Figures
Table Key Players of Drug Therapy
Figure Dialysis Figures
Table Key Players of Dialysis
Figure Kidney Transplant Figures
Table Key Players of Kidney Transplant
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Primary FSGS Case Studies
Figure Secondary FSGS Case Studies
Figure Focal Segmental Glomerulosclerosis (FSGS) Treatment Report Years Considered
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size 2014-2025 (Million US$)
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Regions 2014-2019
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Regions 2014-2019
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Manufacturers in 2018
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Product/Solution/Service
Table Date of Enter into Focal Segmental Glomerulosclerosis (FSGS) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Share by Type (2014-2019)
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Market Share by Type (2014-2019)
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Share by Application (2014-2019)
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Application in 2018
Figure United States Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share (2018-2019)
Table United States Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Type (2014-2019)
Table United States Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Application (2014-2019)
Figure Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share (2018-2019)
Table Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Type (2014-2019)
Table Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Application (2014-2019)
Figure China Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share (2018-2019)
Table China Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Type (2014-2019)
Table China Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Application (2014-2019)
Figure Japan Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share (2018-2019)
Table Japan Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Type (2014-2019)
Table Japan Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share (2018-2019)
Table Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Application (2014-2019)
Figure India Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share (2018-2019)
Table India Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Type (2014-2019)
Table India Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Application (2014-2019)
Figure Central & South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share (2018-2019)
Table Central & South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Type (2014-2019)
Table Central & South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share by Application (2014-2019)
Table B. Braun Melsungen Company Details
Table B. Braun Melsungen Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019) (Million US$)
Figure B. Braun Melsungen Revenue Growth Rate in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
Table B. Braun Melsungen Recent Development
Table Medtronic Company Details
Table Medtronic Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)(Million US$)
Figure Medtronic Revenue Growth Rate in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
Table Medtronic Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Complexa Company Details
Table Complexa Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)(Million US$)
Figure Complexa Revenue Growth Rate in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
Table Complexa Recent Development
Table Dimerix Company Details
Table Dimerix Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)(Million US$)
Figure Dimerix Revenue Growth Rate in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
Table Dimerix Recent Development
Table Retrophin Company Details
Table Retrophin Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)(Million US$)
Figure Retrophin Revenue Growth Rate in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
Table Retrophin Recent Development
Table Beckman Coulter Inc. (Danaher) Company Details
Table Beckman Coulter Inc. (Danaher) Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)(Million US$)
Figure Beckman Coulter Inc. (Danaher) Revenue Growth Rate in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
Table Beckman Coulter Inc. (Danaher) Recent Development
Table Boston Scientific Corporation Company Details
Table Boston Scientific Corporation Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)(Million US$)
Figure Boston Scientific Corporation Revenue Growth Rate in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
Table Boston Scientific Corporation Recent Development
Table ChemoCentryx Company Details
Table ChemoCentryx Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)(Million US$)
Figure ChemoCentryx Revenue Growth Rate in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
Table ChemoCentryx Recent Development
Table Variant Pharmaceuticals Company Details
Table Variant Pharmaceuticals Revenue in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)(Million US$)
Figure Variant Pharmaceuticals Revenue Growth Rate in Focal Segmental Glomerulosclerosis (FSGS) Treatment Business (2014-2019)
Table Variant Pharmaceuticals Recent Development
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Share by Regions (2019-2025)
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Share by Regions in 2025
Figure United States Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Product (2019-2025)
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Product in 2025
Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application (2019-2025)
Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の物質使用障害（SUD）の治療市場：市場規模・現状・予測
    Global Substance Use Disorders (SUDs) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8091 2019年6月14日 98Pages
    当資料は、物質使用障害（SUD）の治療のグローバル市場について調査・分析したレポートで、種類別（オピオイド中毒、タバコ/ニコチン中毒、アルコール依存）、用途別（病院と診療所、住居（病院以外））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...
  • 世界の炎症性腸疾患（IBD）の治療市場：市場規模・現状・予測
    Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7362 2019年6月14日 98Pages
    当資料は、炎症性腸疾患（IBD）の治療のグローバル市場について調査・分析したレポートで、種類別（TNF阻害剤、アミノサリチル酸、免疫調節剤、コルチコステロイド）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予...
  • 世界の性感染症（STD）の治療市場：市場規模・現状・予測
    Global Sexually Transmitted Diseases (STD) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8027 2019年6月14日 97Pages
    当資料は、性感染症（STD）の治療のグローバル市場について調査・分析したレポートで、種類別（ウイルス感染、細菌感染、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の姿勢起立性頻脈症候群（POTS）の治療市場：市場規模・現状・予測
    Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7871 2019年6月14日 92Pages
    当資料は、姿勢起立性頻脈症候群（POTS）の治療のグローバル市場について調査・分析したレポートで、種類別（一次フォーム、二次フォーム）、用途別（病院、診療所、外来手術センター、研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...
  • 世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測
    Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7488 2019年6月14日 97Pages
    当資料は、リソソーム酸リパーゼ欠乏症（LAAL）の治療のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、腎臓移植、幹細胞移植）、用途別（ウォルマン病、コレステロールエステル蓄積症（CESD））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...
  • 世界のフォーカルアドヒージョンキナーゼ市場2019
    Global Focal Adhesion Kinase Sales Market Report 2019
    QYR9N1112 2019年6月10日 100Pages
    本調査レポートでは、フォーカルアドヒージョンキナーゼの世界市場について調査・分析し、フォーカルアドヒージョンキナーゼのメーカー別販売量、市場シェア分析、種類別販売分析（VS-4718、CT-707、GSK-2256098、シレンギタイド、BI-853520、その他）、用途別販売分析（病院、診療所、そ...
  • 世界の非冷却焦点面アレイ（FPA）赤外線検出器市場2019
    Global Uncooled Focal Plane Array (FPA) Infrared Detector Sales Market Report 2019
    QYR9N5353 2019年6月14日 114Pages
    本調査レポートでは、非冷却焦点面アレイ（FPA）赤外線検出器の世界市場について調査・分析し、非冷却焦点面アレイ（FPA）赤外線検出器のメーカー別販売量、市場シェア分析、種類別販売分析（VOx
    、a-Si
    ）、用途別販売分析（軍事および防衛、自動車、スマートホーム、医学、その他...
  • 世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測
    Global Meningococcal Infections Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7541 2019年6月14日 94Pages
    当資料は、髄膜炎菌感染症の治療のグローバル市場について調査・分析したレポートで、種類別（抗生物質、グルココルチコイド、プロテインC濃縮物）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...
  • 世界の腱炎治療市場：市場規模・現状・予測
    Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8111 2019年6月14日 93Pages
    当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・腱炎治療...
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界のうつ病治療市場：市場規模・現状・予測世界のうつ病治療市場：市場規模・現状・予測 Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest.One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the t…
  • 世界の薬物中毒治療市場：市場規模・現状・予測世界の薬物中毒治療市場：市場規模・現状・予測 Drug addiction is a complex neurobiological disease that requires integrated treatment of the mind, body, and spirit. It is considered a brain disease because drugs change the brain — they change its structure and how it works. Without treatment, these brain changes can be long-lasting. Addiction is…
  • 世界の薬物乱用治療市場：市場規模・現状・予測世界の薬物乱用治療市場：市場規模・現状・予測 Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for t…
  • 世界のフォーカルアドヒージョンキナーゼ市場2019世界のフォーカルアドヒージョンキナーゼ市場2019 The global Focal Adhesion Kinase market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Focal Adhesion Kinase market status and forecast, categorizes the global Focal Adhesion Kinase market size (v…
  • 世界の非冷却焦点面アレイ（FPA）赤外線検出器市場2019世界の非冷却焦点面アレイ（FPA）赤外線検出器市場2019 The global Uncooled Focal Plane Array (FPA) Infrared Detector market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Uncooled Focal Plane Array (FPA) Infrared Detector market status and forecast, c…